EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers

Nithye Parvathy, Nalini Gupta

Journal of Cytology · 2026-04 · 43 (2) · 59-62

DOI: 10.4103/joc.joc_53_26 ↗

At a glance

Übersichtsarbeit in Journal of Cytology, published online on 2026-05-16. Written by Nithye Parvathy and 1 co-authors. Institution: Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Cited 1 times so far (Crossref); 16 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cervical cancer screening has evolved immensely with advances in molecular diagnostics and improved understanding of human papillomavirus (HPV)-mediated carcinogenesis. While conventional cervical cytology has historically played a pivotal role in reductions in cervical cancer incidence and mortality, its limitations have led to the development of liquid-based cytology (LBC) and HPV-based testing. LBC offers improved sample adequacy, better preservation of cellular morphology, and permits the use of residual material for ancillary testing. HPV DNA testing, particularly as a primary screening modality, provides high sensitivity for detecting high-grade cervical intraepithelial neoplasia. In addition, emerging biomarkers such as p16INK4a and Ki-67 dual staining enhance risk stratification and triage of HPV-positive women. Despite the growing adoption of primary HPV screening, cytology remains indispensable for morphologic assessment, detection of HPV-independent lesions, and clinical correlation. An integrated approach combining HPV testing, cytology, and biomarkers represents the most effective strategy for cervical cancer screening. Such a balanced model is essential for optimizing diagnostic accuracy, guiding management, and supporting global efforts toward cervical cancer elimination.

Subjects

Author keywords

Cervical cancerHPV testingPap sampleliquid-based cytology

Authors and institutions

  • Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Cytology and Gynecologic Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Cite

APA

Parvathy, N., & Gupta, N. (2026). Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers. Journal of Cytology, 43(2), 59-62. https://doi.org/10.4103/joc.joc_53_26

Vancouver

Parvathy N, Gupta N. Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers. Journal of Cytology. 2026;43(2):59-62. doi:10.4103/joc.joc_53_26

BibTeX
@article{Parvathy2026,
  author = {Parvathy, Nithye and Gupta, Nalini},
  title = {Cervical Cancer Screening in the Molecular Era: Integrating Cytology, Human Papillomavirus Testing, and Biomarkers},
  journal = {Journal of Cytology},
  year = {2026},
  volume = {43},
  number = {2},
  pages = {59--62},
  doi = {10.4103/joc.joc_53_26}
}
Start for free →